Privacy AI
Regulatory

Health data compliance, handled.

Tell us what you need. We'll tell you what it takes and how long, before you commit.

Contact us

Summary

Contact us
A research conducted by Google DeepMind and numerous universities looks at how easily an outsider, without any prior knowledge of the data used to train a machine learning model, can get this information just by asking the model questions. We found that an adversary can pull out a lot of data, even gigabytes, from publicly available language models like Pythia or GPT-Neo, semi-public ones like LLaMA or Falcon, and private models like ChatGPT.

‍

‍

Key Findings:

- Vulnerabilities in Language Models: The research identifies vulnerabilities across various types of Language Models, ranging from open source (Pythia) to closed models (ChatGPT), and semi-open models (LLaMa). The vulnerabilities in semi-open and closed models are particularly concerning due to the non-public nature of their training data.

- Focus on Extractable Memorization: The study delves into the risks of extractable memorization, where data can be efficiently extracted from a machine learning model without prior knowledge of the training dataset.

- Enhanced Data Extraction Capabilities: The attack model developed by the researchers enables the extraction of training data at rates exceeding 150% compared to normal Language Model usage.

- Ineffectiveness of Data Deduplication: The research indicates that deduplication of training data does not significantly reduce the amount of data that can be extracted.

- Uncertainties in Data Handling: The study highlights ongoing uncertainties in how training data is processed and retained by Language Models.

Contact us

FAQs

Our frequently questions

No items found.

Seamus Larroque

CDPO / CPIM / ISO 27005 Certified

Find out how iliomad can help your company.

[Map placeholder]
Only visible in production
38.709099
-39.182035
1.6
6d17042a3425c5b3
Your message has been received!
We'll get back to you as soon as possible.
Something went wrong, please try again.
Home

Discover our latest articles

View All Blog Posts
Diagram showing the layered application of GDPR and Spanish LOPDGDD for subject data rights in clinical trials, with AEPD oversight illustrated
October 16, 2026
Regulations & Guidelines
GDPR
DPIA
Health Data Strategy
Regulation

Subject Data Rights in Clinical Trials: Spain's Health Data Framework Under GDPR

Spain supplements GDPR with LOPDGDD and AEPD guidance for health research. Learn how to manage subject data rights in clinical trials compliantly.

Abstract illustration of interconnected nodes representing clinical trial data flows, wearable devices and EU regulatory symbols against a dark blue background
October 14, 2026
Regulations & Guidelines
GDPR
Clinical Trials
LLMS
Software as a Medical Device (SaMD)

Weekly Privacy, AI and Clinical Trials Digest: Smart Glasses, GDPR Deadlock, Healthcare Cyber Threats and EU Biotech Act Upheaval

This week: EDPB targets smart glasses makers, EU Digital Omnibus stalls, CTIS faces 70% rebuild, healthcare cyberattacks surge and Italy enforces the EU AI Act.

Researcher reviewing AI-generated diagnostic imaging data on a screen in a clinical trial setting, with GDPR compliance documents visible on a desk
October 12, 2026
Regulations & Guidelines
GDPR
LLMS
US Privacy Law
Health Data Strategy

Medical trials and AI: navigating the GDPR, EHDS and EU AI Act overlap

Legal uncertainty surrounds AI use in medical trials. Learn how GDPR, the EHDS and the EU AI Act interact and what sponsors must do to stay compliant.